Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

IFM Due signs immunotherapy deal with Novartis

pharmaceutical-technologySeptember 10, 2019

Tag: IFM , immunotherapy , Deal , Novartis

PharmaSources Customer Service